Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Antidepressants and the risk of death in older patients with depression: A population-based cohort study.

Kollhorst B, Jobski K, Krappweis J, Schink T, Garbe E, Schmedt N.

PLoS One. 2019 Apr 15;14(4):e0215289. doi: 10.1371/journal.pone.0215289. eCollection 2019.

2.

Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.

Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-Ladner U, Niehues T, Überla K, Vygen-Bonnet S, Weinke T, Wiese-Posselt M, Wojcinski M, Zepp F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1. German. No abstract available.

PMID:
30899964
3.

Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.

Masclee GMC, Straatman H, Arfè A, Castellsague J, Garbe E, Herings R, Kollhorst B, Lucchi S, Perez-Gutthann S, Romio S, Schade R, Schink T, Schuemie MJ, Scotti L, Varas-Lorenzo C, Valkhoff VE, Villa M, Sturkenboom MCJM.

PLoS One. 2018 Nov 1;13(11):e0204746. doi: 10.1371/journal.pone.0204746. eCollection 2018.

4.

Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project.

Schink T, Kollhorst B, Varas Lorenzo C, Arfè A, Herings R, Lucchi S, Romio S, Schade R, Schuemie MJ, Straatman H, Valkhoff V, Villa M, Sturkenboom M, Garbe E.

PLoS One. 2018 Sep 19;13(9):e0203362. doi: 10.1371/journal.pone.0203362. eCollection 2018.

5.

Sodium-glucose co-transporter-2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case-control study.

Schmedt N, Andersohn F, Walker J, Garbe E.

Diabetes Obes Metab. 2019 Jan;21(1):52-60. doi: 10.1111/dom.13480. Epub 2018 Aug 28.

PMID:
30047217
6.

Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M.

J Mol Med (Berl). 2018 Aug;96(8):765-775. doi: 10.1007/s00109-018-1661-6. Epub 2018 Jun 22.

PMID:
29934777
7.
8.

Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.

Scholle O, Banaschewski T, Enders D, Garbe E, Riedel O.

J Child Adolesc Psychopharmacol. 2018 Jul/Aug;28(6):415-422. doi: 10.1089/cap.2018.0024. Epub 2018 May 16.

PMID:
29768038
9.

The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study.

Lindemann C, Langner I, Banaschewski T, Garbe E, Mikolajczyk RT.

Front Pediatr. 2017 Oct 24;5:220. doi: 10.3389/fped.2017.00220. eCollection 2017.

10.

Drug-induced kidney injury: A large case series from the Berlin Case-Control Surveillance Study
.

Douros A, Bronder E, Klimpel A, Erley C, Garbe E, Kreutz R.

Clin Nephrol. 2018 Jan;89 (2018)(1):18-26. doi: 10.5414/CN109212.

PMID:
29035197
11.

Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.

Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1395-1402. doi: 10.1002/pds.4289. Epub 2017 Aug 24.

PMID:
28840629
12.

Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.

J Child Adolesc Psychopharmacol. 2017 Nov;27(9):806-813. doi: 10.1089/cap.2016.0202. Epub 2017 Jun 15.

PMID:
28618239
13.

Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24.

PMID:
28544026
14.

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.

Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM.

BMJ. 2017 May 9;357:j1909. doi: 10.1136/bmj.j1909. Review.

15.

Use of azithromycin and risk of ventricular arrhythmia.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM.

CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355.

16.

From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Barrenberg E, Garbe E.

Eur J Clin Pharmacol. 2017 Jul;73(7):901-910. doi: 10.1007/s00228-017-2240-4. Epub 2017 Mar 28.

PMID:
28352949
17.

Initiation and duration of dual antiplatelet therapy after inpatient percutaneous coronary intervention with stent implantation in Germany: An electronic healthcare database cohort study.

Luque Ramos A, Ohlmeier C, Enders D, Linder R, Horenkamp-Sonntag D, Prochaska JH, Mikolajczyk R, Garbe E.

Z Evid Fortbild Qual Gesundhwes. 2017 Feb;120:31-38. doi: 10.1016/j.zefq.2016.12.007. Epub 2017 Feb 7.

PMID:
28284365
18.
19.

Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany.

Castellsague J, Perez-Gutthann S, Calingaert B, Bui C, Varas-Lorenzo C, Arana A, Prados-Torres A, Poblador-Plou B, Gonzalez-Rubio F, Giner-Soriano M, Roso-Llorach A, Linder M, Citarella A, Scholle O, Blenk T, Garbe E.

Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):615-624. doi: 10.1002/pds.4167. Epub 2017 Jan 30.

20.

Supplemental Content

Loading ...
Support Center